Health

South Korea to mass-produce antibody therapy for coronavirus this month

Health researchers are presently analyzing outcomes of the part 1 trial, which was authorized by the drug ministry on July 17.

SEOUL: South Korea plans to mass-produce an antibody therapy of the novel coronavirus later this month, health authorities stated Tuesday.

The nation’s drug ministry is presently reviewing part 2/three medical assessments for the antibody-based therapy and goals to mass-produce business antibodies for the novel coronavirus in September, based on Kwon Jun-wook, deputy chief on the Central Disease Control Headquarters.

Health researchers are presently analysing outcomes of the part 1 trial, which was authorized by the drug ministry on July 17.

They additionally earned approval for the part 1 examine of the therapy in Britain on July 29.

For blood plasma-based therapy, health authorities stated the drug ministry authorized the part 2 examine of its growth on August 20, and 6 medical establishments, together with Samsung Medical Centre and Asan Medical Centre, will confirm its effectiveness and security on COVID-19 sufferers.

Health authorities added the blood plasma materials for the part 2 trial will start being produced Tuesday and provide of the substance shall be accomplished in mid-October.

Related News

Back to top button
Close